0001213900-22-063949.txt : 20221013
0001213900-22-063949.hdr.sgml : 20221013
20221013200855
ACCESSION NUMBER: 0001213900-22-063949
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221012
FILED AS OF DATE: 20221013
DATE AS OF CHANGE: 20221013
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARTELL RON
CENTRAL INDEX KEY: 0001177079
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39138
FILM NUMBER: 221310049
MAIL ADDRESS:
STREET 1: PONIARD PHARMACEUTICALS, INC.
STREET 2: 750 BATTERY STREET, SUITE 330
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jasper Therapeutics, Inc.
CENTRAL INDEX KEY: 0001788028
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 842984849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 6505491400
MAIL ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp
DATE OF NAME CHANGE: 20190912
4
1
ownership.xml
X0306
4
2022-10-12
0
0001788028
Jasper Therapeutics, Inc.
JSPR
0001177079
MARTELL RON
C/O JASPER THERAPEUTICS, INC.
2200 BRIDGE PKWY, SUITE 102
REDWOOD CITY
CA
94065
1
1
0
0
President, CEO and Director
Voting Common Stock
2022-10-12
4
A
0
506250
0.00
A
506250
D
The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
By: /s/ Ronald A. Martell
2022-10-13